economic evaluation of resistant major depressive disorder treat-ment in iranian population: a comparison between repetitive transcranial magnetic stimulation with electroconvulsive

Authors

hesam ghiasvand health services management research center, institute for futures studies in health, kerman university of medical sciences, ker-man, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (kerman university of medical sciences)

mohammad moradi- joo cancer research center, shahid beheshti university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences)

nazanin abolhassani department of health management and economics, school of public health, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

hamid ravaghi assistant professor, department of health services management, school of health management and information sciences, iran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences)

abstract

background: it is estimated that major depression disorders constitute 8.2% of years lived with disability (ylds) globally. the repetitive transcranial magnetic stimulation (rtms) and electroconvulsive therapy (ect) are two relative common interventions to treat major depressive disorders, especially for treatment resistant depression. in this study the cost- effectiveness and cost-utility of rtms were compared with ect in iranian population suffering from major depressive disorder using a decision tree model.   methods: a decision tree model conducted to compare the cost-effectiveness ratio of rtms with ect in a health system prospective and 7 months' time horizon. the outcome variables were: response rate, remission rate and quality-adjusted life-years (qalys) of the rtms and ect as primary and secondary outcomes extracted from systematic reviews and randomized control trials. the costs were also calculated through a field study in one clinic and one hospital; the direct costs have only been considered.   results: the total cost for rtms and ectstrategieswere11015000rials (373us$) and 11742700 rials (397.7us$), respectively. also the rtms/ect ratio of costs per improved patients was 1194410rials (40.5 us$); the ratio for costs per qalys utility was 21017139 rials (711.72 us$). the incremental cost- effectiveness ratio of rtms versus ect was 1194410 rials (40.44 us$) after treatment and maintenance courses.   conclusion: given the current prevalence of depressive disorders in iranian population, the ect is more cost-effective than tms. the sensitivity analysis showed that if the prevalence of major depressive disorders declines to below 5% or the costs of rtms decrease (rtms provided by public sector), then the rtms becomes more cost-effective compared with ect. however, efficacy of rtms depends on the frequency of pulsed magnetic field, the location of rtms on the head, the number of therapeutic sessions and the length of each session.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Economic evaluation of resistant major depressive disorder treat-ment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive

Background: It is estimated that major depression disorders constitute 8.2% of years lived with disability (YLDs) globally. The repetitive Transcranial Magnetic Stimulation (rTMS) and Electroconvulsive Therapy (ECT) are two relative common interventions to treat major depressive disorders, especially for treatment resistant depression. In this study the cost- effectiveness and cost-utility of r...

full text

Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive

BACKGROUND It is estimated that major depression disorders constitute 8.2% of years lived with disability (YLDs) globally. The repetitive Transcranial Magnetic Stimulation (rTMS) and Electroconvulsive Therapy (ECT) are two relative common interventions to treat major depressive disorders, especially for treatment resistant depression. In this study the cost- effectiveness and cost-utility of rT...

full text

Repetitive transcranial magnetic stimulation for major depressive disorder: a review.

Several studies demonstrated that repetitive transcranial magnetic stimulation (rTMS) is an efficacious treatment for treatment-resistant major depressive disorder (TRD). Recent metaanalyses and more recent large multicentre studies provided evidence suggesting that rTMS is indeed a promising treatment; however, its efficacy has often been shown to be modest, compared with sham stimulation. We ...

full text

Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation in Adolescents with Major Depressive Disorder

OBJECTIVES It is estimated that 30-40% of adolescents with major depressive disorder (MDD) do not receive full benefit from current antidepressant therapies. Repetitive transcranial magnetic stimulation (rTMS) is a novel therapy approved by the US Food and Drug Administration to treat adults with MDD. Research suggests rTMS is not associated with adverse neurocognitive effects in adult populati...

full text

A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression.

BACKGROUND Studies published over the past few years suggest that transcranial magnetic stimulation (TMS) may have significant antidepressant actions. In a previous report, we compared electroconvulsive therapy (ECT) and repetitive TMS (rTMS) and found ECT to be superior for psychotic major depression (MD); however, ECT and rTMS had similar results in nonpsychotic MD. We now report on a control...

full text

An Open-Label Feasibility Trial of Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Major Depressive Episodes.

Repetitive transcranial magnetic stimulation (rTMS) has been reported to be a new treatment option for treatment-resistant depression. In Japan, there has been limited research into its feasibility, efficacy, and tolerability. We have launched a trial of rTMS for treating medication-resistant major depressive disorder and bipolar depression. We are investigating low-frequency rTMS to the right ...

full text

My Resources

Save resource for easier access later


Journal title:
medical journal of islamic republic of iran

جلد ۳۰، شماره ۱، صفحات ۱۶۳-۱۷۴

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023